-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In-hospital cardiac arrest (IHCA) is a major adverse event with a high mortality rate if not treated properly.
CPR as an auxiliary means of conventional CPR, is a promising IHCA treatment.
evidence of post-ECPR neurological outcomes is still scarce.
, researchers conducted a comprehensive systematic search of all studies as of December 20, 2019, in a study published in Critical Care, an authoritative journal in critical care medicine.
results of the study were ECPR post-ECPR neurological outcomes after discharge, measured by the Brain Function Classification (CPC) score.
score of 1 or 2 was defined as a favorable outcome, and the secondary outcome of the study was post-hospital mortality.
researchers conducted a meta-analysis of fixed effects.
1,215 results, 19 of which were included in the system's evaluation.
survival rate of the subjects was 30% (95% CI was 28-33%, I2 was 0%, p was 0.24).
percentage of survivors who received good neurological outcomes was 84% (95% CI was 80-88%, I2 was 24%, p was 0.90).
result, ECPR treatment in patients with cardiac arrest in hospitals can lead to good neurological outcomes for most patients, and the survival rate of patients is higher than that described in the CCPR literature.
since ECPR's adaptation may widen to older or weaker patients, research should focus on improving patient survival while maintaining optimal neurological outcomes for patients.
.
